A review of nebulized drug delivery in COPD

by Tashkin, Donald P
Published 2016

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease

by Tashkin, Donald P, Ferguson, Gary T
Published 2013

Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trial

by Kesten, Steven, Celli, Bartolome, Decramer, Marc, Liu, Dacheng, Tashkin, Donald
Published 2011

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial

by Tashkin, Donald P, Leimer, Inge, Metzdorf, Norbert, Decramer, Marc
Published 2015

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials

by Cooper, Christopher B, Anzueto, Antonio, Decramer, Marc, Celli, Bartolome, Tashkin, Donald P, Leimer, Inge, Kesten, Steven
Published 2011

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial

by Halpin, David M. G., Decramer, Marc, Celli, Bartolome, Kesten, Steven, Leimer, Inge, Tashkin, Donald P.
Published 2011

Exacerbation frequency and course of COPD

by Halpin, David MG, Decramer, Marc, Celli, Bartolome, Kesten, Steven, Liu, Dacheng, Tashkin, Donald P
Published 2012

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease

by Celli, Bartolome R, Decramer, Marc, Lystig, Theodore, Kesten, Steven, Tashkin, Donald P
Published 2012

Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial

by Celli, Bartolomé R., Decramer, Marc, Liu, Dacheng, Metzdorf, Norbert, Asijee, Guus M., Tashkin, Donald P.
Published 2016

Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses

by Tashkin, Donald P., Chipps, Bradley E., Trudo, Frank, Zangrilli, James G.
Published 2014

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD

by Tashkin, Donald P, Li, Ning, Kleerup, Eric C, Halpin, David, Celli, Bartolome, Decramer, Marc, Elashoff, Robert
Published 2014

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

by Halpin, David MG, Dahl, Ronald, Hallmann, Christoph, Mueller, Achim, Tashkin, Donald
Published 2015

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

by Tashkin, Donald P, Doherty, Dennis E, Kerwin, Edward, Matiz-Bueno, Carlos E, Knorr, Barbara, Shekar, Tulin, Banerjee, Sibabrata, Staudinger, Heribert
Published 2012

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subj...

by Doherty, Dennis E, Tashkin, Donald P, Kerwin, Edward, Knorr, Barbara A, Shekar, Tulin, Banerjee, Sibabrata, Staudinger, Heribert
Published 2012

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of...

by Tashkin, Donald P, Doherty, Dennis E, Kerwin, Edward, Matiz-Bueno, Carlos E, Knorr, Barbara, Shekar, Tulin, Gates, Davis, Staudinger, Heribert
Published 2012

Comparison of the variability of the annual rates of change in FEV1 determined from serial measurements of the pre- versus post-bronchodilator FEV1 over 5 years in mild to moderate...

by Tashkin, Donald P, Wang, He-Jing, Halpin, David, Kleerup, Eric C, Connett, John, Li, Ning, Elashoff, Robert
Published 2012

The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD)

by Park, Hye Yun, Man, S. F. Paul, Tashkin, Donald, Wise, Robert A., Connett, John E., Anthonisen, Nicholas A., Sin, Don D.
Published 2013

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease: Results from a...

by Rennard, Stephen I., Tashkin, Donald P., McElhattan, Jennifer, Goldman, Mitchell, Ramachandran, Sulabha, Martin, Ubaldo J., Silkoff, Philip E.
Published 2012

One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD

by Donohue, James F., Hanania, Nicola A., Make, Barry, Miles, Matthew C., Mahler, Donald A., Curry, Lisa, Tosiello, Robert, Wheeler, Alistair, Tashkin, Donald P.
Published 2014

HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation

by Baay-Guzman, Guillermina J, Bebenek, Ilona G, Zeidler, Michelle, Hernandez-Pando, Rogelio, Vega, Mario I, Garcia-Zepeda, Eduardo A, Antonio-Andres, Gabriela, Bonavida, Benjamin, Riedl, Marc, Kleerup, Eric, Tashkin, Donald P, Hankinson, Oliver, Huerta-Yepez, Sara
Published 2012